Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus

被引:82
作者
de Jonge, Pieter J. F.
Steyerberg, Ewout W.
Kuipers, Ernst J.
Honkoop, Pieter
Wolters, Leonieke M. M.
Kerkhof, Marjon
van Dekken, Horman
Siersema, Peter D.
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, NL-3000 DR Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands
[3] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.1111/j.1572-0241.2006.00626.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: To identify risk factors for esophageal adenocarcinoma (EAC) in patients with Barrett's esophagus (BE). METHODS: A hospital-based case-control study was performed in which 91 cases with EAC and 244 controls with histologically confirmed BE (> 2 cm) with no dysplasia or low-grade dysplasia were included. Information on demographic, anthropometric, and lifestyle characteristics, physical activity levels, working posture, family history, gastroesophageal reflux disease (GERD) symptoms, and medication use was collected by questionnaire. RESULTS: Cases more often were current smokers (odds ratio 3.7, 95% confidence interval 1.4-9.9), more often had a body mass index > 25 assessed at age 20 (2.6, 1.2-5.5), and more frequently had been working in a stooped posture at age 20 (2.0, 1.1-3.9), compared to controls. In addition, cases less often experienced symptoms of heartburn (0.3, 0.2-0.5) and less frequently used proton pump inhibitors (0.1, 0.05-0.2), compared to controls, whereas use of nonsteroidal anti-inflammatory drugs/aspirin was more common among cases (1.8, 1.1-3.2). Cases more often were men, compared to controls (91% vs 67%, p < 0.001). CONCLUSION: In patients with BE, the risk of EAC is related to risk factors for GERD, which is, however, asymptomatic. As these risk factors are common in Western countries, they are probably not helpful in individualization of surveillance intervals.
引用
收藏
页码:1421 / 1429
页数:9
相关论文
共 47 条
[11]   Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus [J].
不详 .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10) :1865-1865
[12]   Adenocarcinoma in situ arising from the submucosal oesophageal mucous glands [J].
Fabre, A ;
Tansey, DK ;
Dave, U ;
Wright, M ;
Teare, JP ;
Rosin, DR ;
Thompson, ME .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (09) :1047-1049
[13]   Barrett's oesophagus:: from metaplasia to dysplasia and cancer [J].
Fléjou, JF .
GUT, 2005, 54 :I6-I12
[14]   17p (p53) allelic losses, 4N (G(2)/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus [J].
Galipeau, PC ;
Cowan, DS ;
Sanchez, CA ;
Barrett, MT ;
Emond, MJ ;
Levine, DS ;
Rabinovitch, PS ;
Reid, BJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :7081-7084
[15]   Risk factors for dysplasia in patients with Barrett's esophagus (BE) - Results from a multicenter consortium [J].
Gopal, DV ;
Lieberman, DA ;
Magaret, N ;
Fennerty, MB ;
Sampliner, RE ;
Garewal, HS ;
Falk, GW ;
Faigel, DO .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (08) :1537-1541
[16]   THE ROLE OF SMOKING AND ALCOHOL IN METAPLASIA AND CANCER RISK IN BARRETTS COLUMNAR LINED ESOPHAGUS [J].
GRAY, MR ;
DONNELLY, RJ ;
KINGSNORTH, AN .
GUT, 1993, 34 (06) :727-731
[17]   Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years [J].
Hage, M ;
Siersema, PD ;
van Dekken, H ;
Steyerberg, EW ;
Dees, J ;
Kuipers, EJ .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) :1175-1179
[18]  
HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1
[19]   BARRETTS ESOPHAGUS - DEVELOPMENT OF DYSPLASIA AND ADENOCARCINOMA [J].
HAMEETEMAN, W ;
TYTGAT, GNJ ;
HOUTHOFF, HJ ;
VANDENTWEEL, JG .
GASTROENTEROLOGY, 1989, 96 (05) :1249-1256
[20]   THE RELATIONSHIP BETWEEN COLUMNAR EPITHELIAL DYSPLASIA AND INVASIVE ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS [J].
HAMILTON, SR ;
SMITH, RRL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (03) :301-312